Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …

In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD)
challenging the paradigms that had been holding the scene over the previous 30 years …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. In
some patients with NAFLD, isolated steatosis can progress to advanced stages with non …

Nonalcoholic fatty liver disease is associated with both sub... : Medicine Nonalcoholic fatty liver
disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
West, and is also increasing alarmingly in South Asia, reaching an epidemic proportion of …

Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver damage
from the more prevalent (75%–80%) and nonprogressive nonalcoholic fatty liver (NAFL) …

Backgrounds Nonalcoholic fatty liver disease (NAFLD) is linked to obesity and metabolic
syndrome conditions. However, a subset of NAFLD patients express a normal or low body …

Introduction: A number of researches have explored the association between obesity and
nonalcoholic fatty liver disease (NAFLD) liver function, histopathology, complications …

OBJECTIVES: The precise prevalence and risk factors for the development of nonalcoholic
fatty liver disease (NAFLD) in nonobese adults remains unclear. The objective of this study …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of incidental elevation
of liver enzymes in North America and Europe. Risk factors for NAFLD include body mass …